Call us at (412) 454-5582 for a free consultation

August 21, 2026

Federal Hemp Law Changes in 2026

For years, products labeled as hemp, THCA, delta-8, or CBD have occupied a complicated space between federal cannabis law, state law, agricultural regulation, and criminal enforcement. That legal landscape is scheduled to change again on November 12, 2026.

Congress has enacted a substantially narrower federal definition of hemp. The new language focuses on total tetrahydrocannabinol, expressly includes tetrahydrocannabinolic acid, restricts certain manufactured cannabinoids, and creates a separate 0.4 milligram limit for certain finished hemp-derived cannabinoid products.

For Pennsylvania consumers, retailers, and anyone facing a drug investigation, the important point is not simply that “hemp is being banned.” That description is too broad. Industrial hemp remains protected under the new framework, while Congress has targeted particular cannabinoid products and methods of production.

The criminal-law consequences are more important. Hemp has been excluded from the federal Controlled Substances Act definition of marijuana. When a product no longer qualifies as hemp, that exclusion may no longer protect it.

As of August 21, 2026, the scheduled November effective date has not been eliminated. The Senate has approved legislation that would briefly delay most of the new requirements, but that proposal has not completed the legislative process. Anyone relying on hemp’s federal legal status should understand both the law that has already been enacted and the legislation that could still change it.

What Did the 2018 Farm Bill Do With Hemp?

The Agriculture Improvement Act of 2018 created the modern federal distinction between marijuana and hemp.

Under the current statutory definition, hemp generally includes Cannabis sativa and its derivatives when the concentration of delta-9 tetrahydrocannabinol does not exceed 0.3 percent on a dry-weight basis. Congress also removed qualifying hemp from the federal Controlled Substances Act definition of marijuana.

That change helped create markets for cannabidiol, commonly called CBD, as well as products containing delta-8 tetrahydrocannabinol, THCA, and other cannabinoids.

The legal distinction was never quite as simple as saying that anything below 0.3 percent delta-9 tetrahydrocannabinol was automatically legal in every context. Agricultural testing already accounts for the potential conversion of THCA when determining whether hemp crops satisfy regulatory standards. Pennsylvania’s Department of Agriculture likewise explains that hemp lots exceeding 0.3 percent total tetrahydrocannabinol after applicable testing considerations can require remediation or destruction. Pennsylvania Department of Agriculture hemp program guidance

The larger issue developed after harvested hemp entered the consumer market. Products could meet the existing federal definition while containing cannabinoids or concentrations capable of producing intoxicating effects.

Congress has now addressed that issue by narrowing the statutory definition itself.

What Changes on November 12, 2026?

Public Law 119-37 amended the federal hemp definition, with the amendments scheduled to take effect on November 12, 2026.

Under the new definition, qualifying hemp generally must remain at or below 0.3 percent total tetrahydrocannabinols on a dry-weight basis, including tetrahydrocannabinolic acid.

The law also excludes several categories of hemp-derived cannabinoid products. According to the current Congressional Research Service analysis, those exclusions include products containing cannabinoids that cannot naturally be produced by Cannabis sativa, naturally occurring cannabinoids that were synthesized or manufactured outside the plant, certain intermediate cannabinoid products exceeding the new total tetrahydrocannabinol standard, and certain finished products exceeding the new per-container limit. Congressional Research Service analysis of the 2026 hemp definition changes

This is more than a technical agricultural amendment. It changes which cannabis products receive the federal legal protection associated with the word “hemp.”

The 0.4 Limit Is Not 0.4 Percent

One of the most important points to understand is that Congress did not simply change the legal hemp limit from 0.3 percent to 0.4 percent.

The basic concentration threshold in the amended definition remains 0.3 percent total tetrahydrocannabinols for the relevant plant material and intermediate products.

The separate 0.4 figure applies to certain finished hemp-derived cannabinoid products. The statute excludes a final hemp-derived cannabinoid product containing greater than 0.4 milligrams combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, together with certain other cannabinoids determined to have similar effects.

A percentage and a milligram-per-container limit measure different things.

The federal government has acknowledged the practical significance of this distinction. In an April 2026 Federal Register publication, the Centers for Medicare and Medicaid Services described the amended law and stated that final products for human use containing more than 0.4 milligrams per container of the relevant cannabinoids would fall outside the amended hemp definition. The agency also recognized the November 12, 2026 effective date. April 2026 Federal Register discussion of the amended hemp definition

For consumers accustomed to seeing gummies, oils, tinctures, beverages, and full-spectrum products labeled with amounts measured per serving, a per-container federal threshold is particularly significant.

Why THCA Is Central to the New Definition

THCA, or tetrahydrocannabinolic acid, is a naturally occurring cannabinoid found in cannabis. When exposed to heat, THCA can convert into delta-9 tetrahydrocannabinol.

That chemistry is one reason THCA has been central to debates over the 2018 Farm Bill.

Some retail products have been marketed as “THCA hemp” because their measured delta-9 tetrahydrocannabinol concentration fit within the existing statutory hemp definition even when the product contained substantially more THCA.

The 2026 amendment addresses that distinction directly by including THCA when total tetrahydrocannabinols are calculated.

For products sold primarily because of high THCA content, that could be decisive.

It is also important not to confuse this hemp issue with the separate federal debate over marijuana scheduling. PKN Law has previously explained why federal cannabis rescheduling does not amount to legalization. The hemp definition and marijuana scheduling involve different legal mechanisms, even though both affect cannabis policy.

What Happens to Delta-8 and Other Manufactured Cannabinoids?

The amendment is also directed at cannabinoids created through manufacturing or conversion processes.

The new definition excludes hemp-derived cannabinoid products containing cannabinoids that cannot naturally be produced by Cannabis sativa. It also excludes products containing cannabinoids that can occur naturally but were synthesized or manufactured outside the plant.

That language can affect products produced by converting hemp-derived CBD into intoxicating cannabinoids.

Not every cannabinoid or production method should be treated as legally identical. The precise status of a product may depend on what cannabinoid it contains, whether the compound occurs naturally, how it was produced, its concentration, the amount in the final container, and future federal guidance.

That is why a package saying “hemp derived” does not necessarily answer the legal question.

Could Non-Intoxicating CBD Products Be Affected?

Yes. That concern is one of the principal reasons the hemp debate remains active in Washington.

CBD itself does not produce the same intoxicating effect associated with delta-9 tetrahydrocannabinol. However, many full-spectrum hemp products contain small amounts of naturally occurring tetrahydrocannabinols along with CBD and other cannabinoids.

The Food and Drug Administration has long distinguished CBD from tetrahydrocannabinol while also cautioning that the regulatory status of cannabis-derived consumer products depends on more than whether the plant source meets the federal hemp definition. Food and Drug Administration guidance concerning cannabis and CBD products

Because the new law applies a very low per-container threshold to certain finished cannabinoid products, some products not marketed for intoxication could nevertheless fall outside the amended definition.

That does not mean every CBD product will become illegal. Products differ considerably in formulation. Some contain no measurable tetrahydrocannabinol, while others are intentionally sold as full-spectrum products containing multiple cannabinoids.

The composition of the actual product matters.

Congress Could Still Change the November Deadline

The November 12 date remains important, but the legislative situation is still developing.

The Congressional Research Service reported on August 17, 2026 that the Senate had passed a continuing resolution containing language that would delay most of the new hemp definition until December 11, 2026. Certain products containing cannabinoids that cannot naturally be produced by the cannabis plant would still be affected on November 12 under the Senate proposal.

That Senate vote did not itself change current law. The House must agree to legislation and the President must sign it before the statutory effective date changes. As of August 21, the November 12 date therefore remains the operative deadline.

Other bills pending in Congress take different approaches. Some would provide a longer delay. Others would repeal the new definition, raise allowable tetrahydrocannabinol thresholds, defer more heavily to state law, or establish a federal regulatory system for hemp-derived cannabinoid products.

There is no guarantee that any particular proposal will become law.

The White House Has Asked Congress to Revisit the Hemp Framework

The current administration has also taken the unusual position of asking Congress to reconsider at least part of the enacted restrictions.

In a June 24, 2026 budget request, the White House Office of Management and Budget stated that the administration strongly supports revising federal hemp regulation to ensure what it called fair treatment of hemp products. The administration requested either a revision consistent with a pending House proposal or, at minimum, an extension of the implementation period for Section 781 of Public Law 119-37. White House June 2026 request concerning federal hemp regulation

That position does not suspend the law.

Only Congress can amend the statutory definition that Congress enacted. Until legislation actually becomes law, consumers and businesses should not treat political support for a change as if the change has already occurred.

What Does the Federal Hemp Change Mean in a Criminal Case?

The hemp definition matters because federal controlled-substance law expressly excludes qualifying hemp from the definition of marijuana.

When a substance qualifies as hemp, that exclusion can be an important part of the legal analysis. When a product is excluded from the hemp definition, the Controlled Substances Act may apply differently.

The April 2026 Federal Register publication addressed that consequence directly. It stated that, absent subsequent changes, products that fail to comply with the amended hemp definition after its effective date would be treated as controlled substances under federal law.

A criminal prosecution, however, still requires more than pointing to a retail label.

Depending on the charge, important questions can include:

  • What substance did law enforcement actually seize?
  • What cannabinoids were present?
  • What testing method did the laboratory use?
  • What was the measured concentration or amount?
  • Does the government’s test distinguish between tetrahydrocannabinol and tetrahydrocannabinolic acid?
  • How was the product manufactured?
  • When did the alleged possession or distribution occur?
  • Which version of the statute applied at that time?
  • Did officers lawfully obtain the evidence?
  • Can prosecutors prove knowing possession, distribution, or another required element?

Those are the kinds of evidentiary and constitutional questions that arise regularly in Pennsylvania and federal drug cases.

A product’s commercial packaging may be evidence, but it is not necessarily the final legal determination.

Federal Law and Pennsylvania Law Are Separate Questions

Pennsylvania residents should also be careful about assuming that a federal hemp classification automatically answers every state-law question.

Pennsylvania maintains its own controlled-substance statutes, medical marijuana program, agricultural hemp rules, and criminal procedures.

The Pennsylvania Department of Agriculture currently regulates hemp cultivation and processing through its hemp program. The Commonwealth’s 2026 hemp program remains active and has issued permits to growers and processors.

State and federal law can overlap, but they are not interchangeable.

For example, Pennsylvania’s current recreational marijuana laws are a separate issue. Someone trying to understand the distinction can review PKN Law’s discussion of why cannabis is still not generally legal for adult recreational possession in Pennsylvania.

A product might create questions under federal law, Pennsylvania law, or both. The location of the conduct, type of product, amount, source, timing, and circumstances of possession or distribution can all matter.

Why Laboratory Testing May Become Even More Important

Cases involving hemp-derived products can be analytically complicated because cannabinoids must be identified and quantified.

The new statute makes those details more important.

It is no longer sufficient to ask only whether a laboratory detected delta-9 tetrahydrocannabinol. The amended federal framework can require attention to total tetrahydrocannabinols, THCA, other cannabinoids, how a particular cannabinoid was produced, and how much of the relevant material is present in a container.

That gives defense counsel several areas to examine when testing becomes part of a criminal prosecution.

The analysis may include laboratory methodology, chain of custody, sample preparation, measurement uncertainty, whether the tested material represents the substance actually seized, and whether the government’s evidence proves the statutory classification beyond the standard required in the particular proceeding.

Patrick Nightingale’s background on both sides of the courtroom is useful in cases where the government’s interpretation of scientific or technical evidence needs to be tested carefully. PKN Law handles both state drug matters and federal criminal defense cases involving drug investigations.

What Should Pennsylvania Consumers Do Before November 2026?

Consumers do not need to become chemists or federal regulatory lawyers. They should, however, be cautious about broad claims printed on labels or repeated online.

Terms such as “legal hemp,” “Farm Bill compliant,” “THCA flower,” and “federally legal” may describe how a seller views a product under current law. Those phrases do not guarantee that the same product will receive the same legal treatment after November 12, 2026.

The safest approach is to avoid assuming that a product’s current availability means its legal status cannot change.

Anyone operating a business involving hemp-derived cannabinoid products should obtain advice tailored to regulatory compliance. Anyone questioned, searched, arrested, or charged by law enforcement should address the criminal-law issues separately.

If a Hemp or Cannabis Product Leads to a Criminal Investigation

A changing statute does not eliminate constitutional protections or the government’s burden of proof.

If police seize a product they believe is marijuana or an illegal cannabinoid, the defense may need to examine the stop, search warrant, consent, statements, laboratory evidence, product classification, and the law in effect on the date of the alleged conduct.

That review becomes particularly important during a period when federal definitions are changing and Congress is simultaneously considering amendments to those changes.

Patrick Nightingale has more than 24 years of experience as both a former prosecutor and criminal defense attorney and represents people facing state and federal drug allegations. If you have been charged or are under investigation for a matter involving marijuana, THCA, hemp-derived cannabinoids, distribution, or another controlled substance, you can contact PKN Law to schedule a consultation or call (412) 454-5582.

The law described here is current as of August 21, 2026. Because Congress is actively considering legislation affecting the November deadline, the federal hemp rules should be checked again before relying on them after publication.

This article provides general educational information and is not legal advice for any particular case.

Federal hemp law is scheduled to change on November 12, 2026. The new definition generally uses a 0.3 percent total THC standard that includes THCA and separately excludes certain finished hemp-derived cannabinoid products containing more than 0.4 milligrams of total THC and similar cannabinoids per container. Congress could still modify the deadline.

Frequently Asked Questions

Is THCA federally legal in Pennsylvania in 2026?

The answer depends on the product and timing. Under the current federal framework, some products marketed as THCA hemp may qualify as hemp. The federal definition is scheduled to become narrower on November 12, 2026 and expressly includes THCA in the total tetrahydrocannabinol calculation. Pennsylvania law must also be considered separately.

Is the new federal hemp limit 0.4 percent THC?

No. The 0.4 figure is not a new 0.4 percent concentration limit. The amended law uses a 0.3 percent total tetrahydrocannabinol standard in relevant parts of the hemp definition and separately establishes a 0.4 milligram per-container threshold for certain finished hemp-derived cannabinoid products.

Will all CBD become federally illegal in November 2026?

No. The law does not categorically prohibit CBD. However, some full-spectrum CBD products containing naturally occurring tetrahydrocannabinols could exceed the new per-container threshold and fall outside the amended federal hemp definition. Product composition will matter.

Will delta-8 products still qualify as hemp after November 12, 2026?

Many products may have difficulty qualifying under the amended definition, particularly when cannabinoids were synthesized or manufactured outside the cannabis plant. The legal status of a particular product depends on its cannabinoid content, method of production, and other statutory requirements.

Has Congress delayed the November 12, 2026 hemp deadline?

Not yet as of August 21, 2026. The Senate has passed legislation that would delay most of the new definition until December 11, 2026, but Senate passage alone does not change the law. The House and President would also need to complete the legislative process.

Can I be charged because a product labeled as hemp actually contains marijuana?

Potentially, depending on the facts and applicable law. A commercial label does not necessarily determine a substance’s legal classification. Prosecutors must still prove the elements of the charged offense, and laboratory testing, possession, knowledge, search-and-seizure issues, and the law in effect at the time may all be relevant.

Does the federal hemp change automatically change Pennsylvania marijuana law?

No. Federal and Pennsylvania laws are separate, although they can interact. Pennsylvania has its own controlled-substance laws, medical marijuana program, and hemp regulations. The legal analysis depends on the product, conduct, jurisdiction, and applicable state and federal provisions.

What should I do if police seize a THCA or hemp product in Pennsylvania?

Avoid guessing about the product’s legal status or making unnecessary statements about possession or ownership. A defense attorney can examine the legality of the stop or search, laboratory testing, cannabinoid composition, statutory classification, and the government’s evidence before determining how the law applies.

Recent Posts

Archives

Categories

Tags

Share

Schedule Consultation 

Are you human? Solve this to prove: